Dr Pablo Fernandez is Senior Vice President, Medical Affairs, PharmaNet.
The Changing Landscape For Biosimilars
As biopharmaceuticals will soon make up 50% of new drug approvals there has been a significant rise in interest in the field of biosimilars.